您的购物车当前为空
DOTA-CXCR4-L为针对CXCR4的靶向肽,适用于癌症研究,如胶质母细胞瘤和三阴性乳腺癌。
DOTA-CXCR4-L为针对CXCR4的靶向肽,适用于癌症研究,如胶质母细胞瘤和三阴性乳腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
DOTA-CXCR4-L 相关产品
| 产品描述 | DOTA-CXCR4-L, a peptide targeting the CXCR4 receptor, is utilized in cancer research, notably in the contexts of glioblastoma and triple-negative breast cancer [1]. |
| 分子量 | 1223.34 |
| 分子式 | C58H78N16O14 |
| Sequence | cyclo[{d-Tyr}-{d-(NMe)Orn}-(HYNIC-DOTA)-Arg-{Nal}-Gly)] |
| Sequence Short | cyclo[{d-Tyr}-{d-(NMe)Orn}-(HYNIC-DOTA)-R-{Nal}-G)] |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容